Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “air”

656 pharma patents match "air" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 656
Index total 30,257
Page 1 / 28

Quick answer

This filtered view shows 656 pharmaceutical patents matching "air" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

656 results for “air” · 30,257 patents in full index Clear search

  1. WO 2026093586

    COMBINAISON D'UN INHIBITEUR DE L'ALDOSTÉRONE SYNTHASE (ASI) ET D'UN INHIBITEUR DU CO-TRANSPORTEUR SODIUM-GLUCOSE DE TYPE 2 (SGLT2I) DESTINÉE À ÊTRE UTILISÉE DANS DES MÉTHODES VISANT À RÉDUIRE LE RISQUE D'ÉVÉNEMENTS CARDIOVASCULAIRES ET D'INSUFFISANCE CARDIAQUE CHEZ UN SUJET

    ASTRAZENECA IRELAND LTD [IE] · Granted May 7, 2026 · Expires May 2, 2046

    granted

  2. WO 2026082715

    DÉPLÉTION DES MACROPHAGES ET VIRUS DE LA STOMATITE VÉSICULAIRE POUR LE TRAITEMENT DU CANCER

    BOEHRINGER INGELHEIM INT [DE] · Granted Apr 23, 2026 · Expires Apr 18, 2046

    granted

  3. WO 2026078159

    AGENTS D'ACTIVATION DE CELLULES IMMUNITAIRES ET PROCÉDÉS LES COMPRENANT

    ABLYNX NV [BE] · Granted Apr 16, 2026 · Expires Apr 11, 2046

    granted

  4. WO 2026057739

    POLYTHÉRAPIE COMPRENANT DES ANTICORPS ANTI-CTLA4 ET DES ANTICORPS ANTI-PD-1 POUR LE TRAITEMENT DU CANCER DE L'OVAIRE RÉSISTANT AU PLATINE

    BIONTECH SE [DE] · Granted Mar 19, 2026 · Expires Mar 14, 2046

    granted

  5. WO 2026041123

    VACCINS À VECTEUR DEV CONTRE LA GRIPPE AVIAIRE

    BOEHRINGER INGELHEIM VETMEDICA CHINA CO LTD [CN] · Granted Feb 26, 2026 · Expires Feb 21, 2046

    granted

  6. WO 2026020076

    MÉTHODE DE TRAITEMENT DU PRURIGO NODULAIRE

    AMGEN INC [US] · Granted Jan 22, 2026 · Expires Jan 17, 2046

    granted

  7. WO 2026013162

    VECTEUR VACCINAL DU VIRUS HERPÈS DU DINDON POUR LE TRAITEMENT ET LA PRÉVENTION D'INFECTIONS PROVOQUÉES PAR LE VIRUS DE LA GRIPPE AVIAIRE CHEZ DES DINDONS

    BOEHRINGER INGELHEIM VETMEDICA GMBH [DE] · Granted Jan 15, 2026 · Expires Jan 10, 2046

    granted

  8. WO 2026013161

    VACCINATION DE PREMIÈRE IMMUNISATION ET DE RAPPEL POUR LE TRAITEMENT ET LA PRÉVENTION D'INFECTIONS PROVOQUÉES PAR LE VIRUS DE LA GRIPPE AVIAIRE CHEZ LES AVIENS

    BOEHRINGER INGELHEIM VETMEDICA GMBH [DE] · Granted Jan 15, 2026 · Expires Jan 10, 2046

    granted

  9. WO 2026007883

    COMPOSITION IMMUNOGÈNE CONTRE LE SOUS-TYPE H7 DU VIRUS DE LA GRIPPE AVIAIRE

    BOEHRINGER INGELHEIM VETMEDICA CHINA CO LTD [CN] · Granted Jan 8, 2026 · Expires Jan 3, 2046

    granted

  10. WO 2026007889

    COMPOSITION IMMUNOGÈNE CONTRE LE SOUS-TYPE H7 ET LE SOUS-TYPE H5 DU VIRUS DE LA GRIPPE AVIAIRE

    BOEHRINGER INGELHEIM VETMEDICA CHINA CO LTD [CN] · Granted Jan 8, 2026 · Expires Jan 3, 2046

    granted

  11. WO 2026007886

    COMPOSITION IMMUNOGÈNE CONTRE LE SOUS-TYPE H7 DU VIRUS DE LA GRIPPE AVIAIRE

    BOEHRINGER INGELHEIM VETMEDICA CHINA CO LTD [CN] · Granted Jan 8, 2026 · Expires Jan 3, 2046

    granted

  12. WO 2025207099

    INHIBITEURS DE PPAR-DELTA POUR PRÉVENIR UNE FIBRILLATION AURICULAIRE POST-OPÉRATOIRE

    ASTELLAS PHARMA INC [JP] · Granted Oct 2, 2025 · Expires Sep 27, 2045

    granted

  13. US 12414907

    Peptide having hair growth promoting activity and use thereof

    CAREGEN CO., LTD. · Granted Sep 16, 2025 · Expires Sep 11, 2045

    granted

  14. US 12398123

    Chemical inhibition of the E3 ligase subunit FBXO7 confers neuroprotection and anti-inflammatory activity by stabilizing mitochondria

    United States Government as represented by the Department of Veterans Affairs · Granted Aug 26, 2025 · Expires Aug 21, 2045

    granted

  15. US 12397066

    Delivery of gene therapy treatments

    United States Government as represented by the Department of Veterans Affairs · Granted Aug 26, 2025 · Expires Aug 21, 2045

    granted

  16. US 12383500

    Nanoliposome compositions and methods of using the same

    United States Government as represented by the Department of Veterans Affairs · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted

  17. US 12385010

    Gene therapy for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes

    United States Government as represented by the Department of Veterans Affairs · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted

  18. US 12377036

    Melanin hair dye with thickeners

    Northwestern University · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted

  19. US 12377135

    GHRH antagonists for use in a method of treating sarcoidosis

    United States Government as represented by the Department of Veterans Affairs · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted

  20. US 12357615

    Compositions for the treatment of brain tumors

    United States Government as represented by the Department of Veterans Affairs · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted

  21. US 12357582

    Hydrophobic ion pairing and flash nanoprecipitation for formation of controlled-release nanocarrier formulations

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted

  22. US 12350274

    Nucleotide analogs

    United States Government as represented by the Department of Veterans Affairs · Granted Jul 8, 2025 · Expires Jul 3, 2045

    granted

  23. US 12351625

    Therapeutic antibodies against osteopontin

    United States Government as represented by the Department of Veterans Affairs · Granted Jul 8, 2025 · Expires Jul 3, 2045

    granted

  24. WO 2025133253

    EXCIPIENTS DE CONJUGAISON PROTÉINIQUES POUR ADMINISTRATION INTRANUCLÉAIRE

    ABLYNX NV [BE] · Granted Jun 26, 2025 · Expires Jun 21, 2045

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.